Advertisement

Ads Placeholder
Loading...

Sol-Gel Technologies Ltd.

SLGLNASDAQ
Healthcare
Biotechnology
$79.46
$-4.04(-4.84%)
U.S. Market opens in 26h 42m

Sol-Gel Technologies Ltd. (SLGL) Stock Overview

Explore Sol-Gel Technologies Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap223.3M
P/E Ratio-36.13
EPS (TTM)$-2.19
ROE-0.24%
Fundamental Analysis

AI Price Forecasts

1 Month$79.20
3 Months$102.56
1 Year Target$92.08

SLGL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Sol-Gel Technologies Ltd. (SLGL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.66, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $92.08.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -36.13 and a market capitalization of 223.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.84%
5-Day Change
4.66%
1-Month Change
-18.89%
3-Month Change
88.52%
6-Month Change
128.33%
Year-to-Date (YTD) Change
88.52%
1-Year Change
1489.20%
3-Year Change
99.65%
5-Year Change
-36.74%
All-Time (Max) Change
-41.74%

Contact Information

972 8 931 3433
7 Golda Meir Street, Ness Ziona, NaN, 7403650

Company Facts

340 Employees
IPO DateFeb 1, 2018
CountryIL
Actively Trading

Frequently Asked Questions